4//SEC Filing
Gall Matthew 4
Accession 0000899243-21-024236
CIK 0001808865other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:46 PM ET
Size
4.9 KB
Accession
0000899243-21-024236
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-06-16$26.09/sh+5,000$130,447→ 5,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.84 to $26.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816194
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 6:46 PM ET
- Size
- 4.9 KB